In the latest trading session, 0.41 million Compass Pathways Plc ADR (NASDAQ:CMPS) shares changed hands as the company’s beta touched 2.28. With the company’s most recent per share price at $3.35 changed hands at -$0.02 or -0.74% at last look, the market valuation stands at $228.86M. CMPS’s current price is a discount, trading about -280.6% off its 52-week high of $12.75. The share price had its 52-week low at $3.16, which suggests the last value was 5.67% up since then. When we look at Compass Pathways Plc ADR’s average trading volume, we note the 10-day average is 1.42 million shares, with the 3-month average coming to 1.04 million.
Analysts gave the Compass Pathways Plc ADR (CMPS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CMPS as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Compass Pathways Plc ADR’s EPS for the current quarter is expected to be -0.62.
Compass Pathways Plc ADR (NASDAQ:CMPS) trade information
Instantly CMPS was in red as seen in intraday trades today. With action -29.58%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -11.51%, with the 5-day performance at -29.58% in the red. However, in the 30-day time frame, Compass Pathways Plc ADR (NASDAQ:CMPS) is -26.16% down. Looking at the short shares, we see there were 3.89 million shares sold at short interest cover period of 5.49 days.
The consensus price target for the stock as assigned by Wall Street analysts is 23, meaning bulls need an upside of 85.43% from its recent market value. According to analyst projections, CMPS’s forecast low is 23 with 23 as the target high. To hit the forecast high, the stock’s price needs a -586.57% plunge from its current level, while the stock would need to soar -586.57% for it to hit the projected low.
Compass Pathways Plc ADR (CMPS) estimates and forecasts
Data shows that the Compass Pathways Plc ADR share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -53.02% over the past 6 months, a -0.43% in annual growth rate that is considerably lower than the industry average of 5.10%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
The 2025 estimates are for Compass Pathways Plc ADR earnings to decrease by -1.96%.
CMPS Dividends
Compass Pathways Plc ADR is expected to release its next quarterly earnings report in February.
Compass Pathways Plc ADR (NASDAQ:CMPS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 16.40% of Compass Pathways Plc ADR shares while 35.80% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 42.83%. There are 35.80% institutions holding the Compass Pathways Plc ADR stock share, with TCG CROSSOVER MANAGEMENT, LLC the top institutional holder. As of 2024-06-30, the company held 6.0073% of the shares, roughly 3.86 million CMPS shares worth $23.3 million.
CITADEL ADVISORS LLC holds the second largest percentage of outstanding shares, with 5.7118% or 3.67 million shares worth $22.16 million as of 2024-06-30.
Among Mutual Funds, the top two as of Nov 30, 2024 were ARK ETF Tr-ARK Genomic Revolution ETF and iShares Biotechnology ETF. With 1.87 shares estimated at $6.27 million under it, the former controlled 2.73% of total outstanding shares. On the other hand, iShares Biotechnology ETF held about 0.54% of the shares, roughly 371.72 shares worth around $1.25 million.
